Product Information
MOTPOLY XR 150 MG CAPSULE is a brand product labeled by Aucta Pharmaceuticals, Inc., priced at $21.2942 per EA under NDC 73289006402. Its NADAC has been published 28 times since Dec 17, 2025.
The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Aucta Pharmaceuticals, Inc.NDC
73289006402
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LACOSAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA216185On Market Since
5/5/2023
Pharmacological Classes
Price Statistics
The NADAC for MOTPOLY XR 150 MG CAPSULE has been published 28 times since Dec 17, 2025, and over the history we have for it it has risen 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.2942 per EA |
|---|---|
| All-time high | $21.3116 (May 13, 2026) |
| All-time low | $20.6881 (Dec 17, 2025) |
| 52-week high | $21.3116 |
| 52-week low | $20.6881 |
| Median price | $21.3116 |
| Average price | $21.2188 |
| Largest weekly change | +3.0% (Jan 14, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOTPOLY XR 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MOTPOLY XR 150 MG CAPSULE, manufactured by Aucta Pharmaceuticals, Inc., is $21.2942 per EA (NDC 73289006402), effective Jun 24, 2026.
How has the price of MOTPOLY XR 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MOTPOLY XR 150 MG CAPSULE has risen 2.9%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for MOTPOLY XR 150 MG CAPSULE?
Since Dec 17, 2025, the NADAC for MOTPOLY XR 150 MG CAPSULE has ranged from a low of $20.6881 (Dec 17, 2025) to a high of $21.3116 (May 13, 2026), with a median of $21.3116 per EA.
Are there cheaper alternatives to MOTPOLY XR 150 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LACOSAMIDE 150 MG TABLET, is $0.2075 per EA — about 99% below MOTPOLY XR 150 MG CAPSULE.
Who manufactures MOTPOLY XR 150 MG CAPSULE?
MOTPOLY XR 150 MG CAPSULE (NDC 73289006402) is labeled by Aucta Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification